Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line |
| |
| Authors: | P. J. Hepburn R. T. D. Oliver P. A. Riley B. T. Hill J. R. W. Masters |
| |
| Affiliation: | (1) Department of Histopathology, St. Paul's Hospital, Institute of Urology, London, UK;(2) Department of Oncology, St. Paul's Hospital, Institute of Urology, London, UK;(3) Department of Biochemical Pathology, University College Medical School, London, UK;(4) Laboratory of Cellular Chemotherapy, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, UK |
| |
| Abstract: | Summary Many chemotherapeutic drugs have been used to treat patients with advanced bladder cancer, but few of these have been evaluated adequately in phase II clinical trials. Continuous cell lines provide one means for comparing the in vitro cytotoxicities of anticancer agents. In this study, a continuous cell line derived from a transitional cell cancer of the human bladder, which still produces tumours histologically similar to the tumour of origin on xenotransplantation, was used to measure the in vitro cytotoxicities of twelve chemotherapeutic drugs by clonogenic assay. The most cytotoxic agents tested were methotrexate, mitoxantrone, adriamycin, mitomycin C and cisplatin. These in vitro findings are compatible with the activity of these drugs given systemically as single agents in phase II clinical trials in patients with advanced bladder cancer. |
| |
| Keywords: | Bladder cancer Continuous cell line Chemotherapy |
| 本文献已被 SpringerLink 等数据库收录！ |
|
